Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      EMEA/Our innovation /Focus areas/Immunology /Psoriasis

      Psoriasis

      We understand your stress and fear about psoriasis, and how debilitating this and other immune-mediated diseases can be. That’s why we’re fully committed to pursuing transformational treatments to help you and the millions of other sufferers around the world.
      skin_cells.jpg
      Our focus in dermatology: Psoriasis
      Our main focus is psoriasis, a chronic disease affecting the skin for which there is no cure.[1]

      The most common form of psoriasis is plaque psoriasis, which usually results in patches of thick, red or inflamed skin covered with silvery scales, which are called plaques.[2]
      The unpredictable nature of these plaques means that many patients fear they will return even when their condition has been brought under control.
      JJMTIM_Photo_Piggyback_05_6835 (2).jpg
      What we’ve achieved
      Johnson & Johnson has played a leading role in the advancement of both transformational treatments and understanding of the underlying science of psoriasis for the past decade.

      We’re committed to developing better treatments for those living with psoriasis, given the physical and psychological effect it has on those living with the condition.
      Expand
      We pursue innovative study concepts, such as evaluating the possibility of prolonged treatment intervals or intermittent therapy in psoriasis.

      Our aim is to restore balance to the immune system with innovative treatments that either engage the brakes or block the accelerators of the immune system. In the future we aim to use these therapeutic approaches simultaneously to provide patients with even better outcomes.
      Collapse
      Psoriasis facts
      Psoriasis affects almost 12 million people across Europe.[3],[4]
      One study found that 37% of psoriasis patients have experienced suicidal thoughts.[5]
      The age someone develops psoriasis is often seen to be seen 15 and 25.[6]
      The disease may have a secondary impact on family members. 37% of close relatives and partners felt that their relationships had deteriorated.[7]
      A person with psoriasis will miss on average 306 hours of work a year, equating to an average loss of €6,296 in income per year, due to psoriasis.[8]
      Beyond Expectations patient platform

      If you want to learn more about psoriasis or psoriatic arthritis, check out Beyond Expectations. It’s an online patient portal for those who live with psoriatic disease or are interested in learning more about the disease and treatment options. It’s also a place to connect with others via patient groups.

      The platform provides tips, patient stories, and credible, scientifically supported information to help and encourage people to move forward with their lives. As well as finding inspiration on how to live their lives, we want patients to see that any progress is something to be proud of, and that their condition does not define them.

      We believe that with the right tools there are no limits to what patients can achieve. Every day can – and should – be filled with triumphs, big and small.
      Learn more about Beyond Expectations
      JNJ_BodyIllustration_Exterior_MaleUpperBack_Colorway03
      Freedom from disease: having your say in psoriasis
      Freedom from disease in psoriasis is all about giving the patient an equal say in what it means to be disease free.

      This matters because it’s only by bringing together the voices of doctors, nurses, and their patients that a fuller understanding of what it means to be “free” from psoriasis is possible.
      Explore what it means to be free from disease.

      References

      [1] Psoriasis Association. About Psoriasis. Available at: www.psoriasisassociation.org.uk/psoriasis-and-treatments. Accessed November 2020.
      [2] British Skin Foundation. Psoriasis. Available at: www.britishskinfoundation.org.uk/SkinInformation/AtoZofSkindisease/Psori.... Accessed October 2022.
      [3] Parisi R, Iskandar IYK, Kontopantelis E, et al. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study, supplement. BMJ. 2020;369:m1590
      [4] PopulationPyramid.net. List of countries ordered by their population size. Available at: https://www.populationpyramid.net/population-size-per-country/2017/. Last accessed March 2023.
      [5] Pompili M, Innamorati M, et al. Suicide risk and psychiatric comorbidity in patients with psoriasis. J Int Med Res 2016;44 (1 suppl):61–7.
      [6] National Psoriasis Foundation. About Psoriasis. Available at: https://www.psoriasis.org/about-psoriasis/. Accessed: October 2022.
      [7] Eghlileb A, Davies E and Finlay A. Psoriasis has a major secondary impact on the lives of family members and partners. Br J Dermatol 2007;156:1245–50.
      [8] Mustonen A, et al. How much of the productivity losses among psoriasis patients are due to psoriasis. BMC Health Serv Res. 2015;15:87.

      CP-459038
      September 2024